Immune checkpoint molecule PD-1 is expressed by various immune cells, including tumor-infiltrating CD8(+) T cells and CD4(+) T cells, and is activated by its ligands (either PD-L1 or PD-L2). The gene discussed is CD8A; the disease is neoplasm.